Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00919269
What this trial is testing

Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma

Who this might be right for
Adult RhabdomyosarcomaChildhood Desmoplastic Small Round Cell TumorChordoma+13 more
Children's Oncology Group 150
Not applicableNot Yet RecruitingNCT07102056
What this trial is testing

18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms

Who this might be right for
Neuroendocrine Tumors
First Affiliated Hospital of Zhejiang University 152
Testing effectiveness (Phase 2)Study completedNCT03310372
What this trial is testing

Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Central Hospital, Nancy, France 46
Not applicableLooking for participantsNCT07111195
What this trial is testing

Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)

Who this might be right for
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Juan M Garcia-Gomez 140
Not applicableLooking for participantsNCT06215495
What this trial is testing

A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial

Who this might be right for
Radiation ToxicityMRI Simulated PositioningHigh Grade Glioma+2 more
Zhujiang Hospital 88
Not applicableLooking for participantsNCT06536257
What this trial is testing

Personalised Immunotherapy Platform

Who this might be right for
MelanomaCutaneous Squamous Cell CarcinomaBasal Cell Carcinoma+2 more
Melanoma Institute Australia 1,000
Not applicableActive Not RecruitingNCT02375841
What this trial is testing

Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers

Who this might be right for
Brain CancerGlioblastoma
Memorial Sloan Kettering Cancer Center 309
Testing effectiveness (Phase 2)Active Not RecruitingNCT00937937
What this trial is testing

Dinaciclib in Treating Patients With Stage IV Melanoma

Who this might be right for
Acral Lentiginous MelanomaCutaneous Nodular MelanomaLentigo Maligna Melanoma+4 more
National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)Study completedNCT00040872
What this trial is testing

Multiple Therapies in Treating Patients With Advanced Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center
Not applicableActive Not RecruitingNCT04975139
What this trial is testing

Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks

Who this might be right for
Glioma
Washington University School of Medicine 71
Not applicableLooking for participantsNCT05878977
What this trial is testing

Biomarkers in Immunotherapy of Melanoma

Who this might be right for
Metastatic MelanomaImmune Checkpoints InhibitorsGastrointestinal Microbiome (Bacterial and Viral)+1 more
Institute of Oncology Ljubljana 150
Testing effectiveness (Phase 2)UnknownNCT02928575
What this trial is testing

Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Bassam Abdulkarim 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT04848337
What this trial is testing

Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticNeuroendocrine Tumors
University of Michigan Rogel Cancer Center 45
Not applicableUnknownNCT04216537
What this trial is testing

Survival Significance of Molecular Pathology and Genetic Variation in Brain Gliomas

Who this might be right for
GliomaMolecular Sequence VariationGenetic Change
The First Affiliated Hospital of Zhengzhou University 3,000
Not applicableUnknownNCT05448157
What this trial is testing

68Ga-DOTATOC Radio-Guided Surgery With β-Probe in GEP-NET

Who this might be right for
Neuroendocrine Tumor CarcinoidNeuroendocrine Tumor of PancreasGep Net
European Institute of Oncology 20
Testing effectiveness (Phase 2)WithdrawnNCT01340729
What this trial is testing

Open-Label Study of TPI 287 for Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Testing effectiveness (Phase 2)Ended earlyNCT01122901
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 47
Not applicableLooking for participantsNCT04047264
What this trial is testing

Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions

Who this might be right for
GliomaGlioblastomaMetastatic Malignant Neoplasm in the Brain
Mayo Clinic 100
Early research (Phase 1)Study completedNCT02482532
What this trial is testing

Vaccine Enriched, Autologous, Activated T-Cells Directed to Tumor in Patients With Relapsed/Refractory Melanoma

Who this might be right for
Melanoma
Gary Doolittle 7
Next Page